A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

ClinicalTrials.gov ID: NCT07499232

Public ClinicalTrials.gov record NCT07499232. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 19, 2026, 11:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b, Multicenter, Randomized, Open-Label, Active-Controlled Study to Compare the Efficacy and Safety of Guselkumab Versus Risankizumab in the Treatment of Participants With Moderately to Severely Active Crohn's Disease

Study identification

NCT ID: NCT07499232
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Janssen Research & Development, LLC; Industry
Enrollment: 530 participants

Conditions and interventions

Conditions

Crohn Disease

Interventions

Guselkumab Drug
Risankizumab Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 20, 2026
Primary completion: Nov 14, 2028
Completion: Dec 10, 2030
Last update posted: May 7, 2026

2026 – 2030

United States locations

U.S. sites: 8
U.S. states: 6
U.S. cities: 8

Facility	City	State	ZIP	Site status
Clinnova Research	Anaheim	California	92805	Recruiting
TLC Clinical Research Inc	Los Angeles	California	90048	Recruiting
Peak Gastroenterology Associates	Colorado Springs	Colorado	80907	Recruiting
Sanchez Clinical Research, Inc	Miami	Florida	33157-6575	Recruiting
GCP Clinical Research	Tampa	Florida	33609	Recruiting
Cotton-O'Neil Clinical Research Center	Topeka	Kansas	66606	Recruiting
New York Gastroenterology Associates	New York	New York	10075	Recruiting
Southern Star Research Institute, LLC	San Antonio	Texas	78229	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07499232, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 7, 2026 · Synced May 19, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07499232 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →